SI-BONE, Inc.
SIBNNASDAQHealthcare● Active
$15.23
+$0.11(+0.69%)
Market Cap$675217834
P/E Ratio—
52W High$21.89
52W Low$11.48
SI-BONE, Inc. (SIBN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SIBN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.20B | $0.17B | $0.14B | $0.11B | $0.09B |
| Cost of Revenue | $0.04B | $0.04B | $0.03B | $0.02B | $0.01B |
| Gross Profit | $0.16B | $0.13B | $0.11B | $0.09B | $0.08B |
| Gross Margin %(computed) | 79.57% | 79.03% | 78.78% | 85.24% | 88.43% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| G&A Expenses | $0.04B | $0.03B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.18B | $0.17B | $0.16B | $0.15B | $0.13B |
| Operating Income | ($0.02B) | ($0.04B) | ($0.05B) | ($0.06B) | ($0.05B) |
| Operating Margin %(computed) | -11.11% | -21.08% | -33.79% | -56.02% | -57.31% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.01B |
| Income Before Tax | ($0.02B) | ($0.03B) | ($0.04B) | ($0.06B) | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.02B) | ($0.03B) | ($0.04B) | ($0.06B) | ($0.06B) |
| Net Margin %(computed) | -9.41% | -18.49% | -31.20% | -57.57% | -62.75% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.44 | $-0.75 | $-1.13 | $-1.79 | $-1.71 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.03B | 0.03B |
| EBITDA | ($0.01B) | ($0.02B) | ($0.03B) | ($0.05B) | ($0.05B) |
| EBITDA Margin %(computed) | -5.43% | -13.81% | -24.80% | -51.67% | -56.54% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more SI-BONE, Inc. data
About SI-BONE, Inc. (SIBN) Income Statement
SI-BONE, Inc. (SIBN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SIBN reported revenue of $0.20B, gross profit of $0.16B (gross margin 79.57%), and net income of ($0.02B) — a net profit margin of -9.41%.
Frequently asked questions
SIBN · 4 questionsSI-BONE, Inc. (SIBN) reported revenue of $0.20B for 2025, up 20.2% year-over-year.
SIBN revenueSIBN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08